ReAlta Life Sciences Announces FDA Orphan Drug Designation for PIC1 for the Treatment of Hypoxic-Ischemic Encephalopathy Read more
Immix Doses First Patient in USA in its Phase 1b/2a Trial in Patients with Advanced Solid Tumors Read more
Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660 Read more
Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus Read more
Boehringer Ingelheim receives approval for Aservo EquiHaler, industry first therapy for severe equine asthma Read more
Navrogen and Levena Announce Collaboration to Develop ADCs to Treat Humoral Immuno-Suppressed Cancers Read more
Teva Announces Positive Top-Line Results from AJOVY (fremanezumab) Clinical Trials in Japan Read more